Meyring Michael - EMD Serono & Merck Serono Res & Dev, Merck KGaA

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 75 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure 15 from Arginase 1/2 Inhibitor OATD-02: from Discovery to First-in-man Setup in Cancer Immunotherapy

Bartlomiej Borek,Julita Nowicka,Anna Gzik,Marek Dzięgielewski,Karol Jedrzejczak,Joanna Brzezinska,Marcin Grzybowski,Paulina Stanczak,Paulina Pomper,Agnieszka Zagożdżon,Tomasz Rejczak,Krzysztof Matyszewski, Adam Golebiowski, Jacek Olczak,Kamil Lisiecki,Magdalena Tyszkiewicz,Magdalena Kania,Sylwia Piasecka,Anna Cabaj,Paulina Dera,Krzysztof Mulewski,Jacek Chrzanowski,Damian Kusmirek,Elżbieta Sobolewska,Marta Magdycz,Lukasz Mucha, Marek Masnyk, Jakub Gołąb, Marcin Nowotny,Elżbieta Nowak,Agnieszka Napiórkowska-Gromadzka, Stanislaw Pikul,Radosław Jaźwiec,Karolina Dzwonek, Pawel Dobrzanski,Michael Meyring, Krzysztof Skowronek,Piotr Iwanowski,Zbigniew Zasłona,Roman Błaszczyk

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 21 from Arginase 1/2 Inhibitor OATD-02: from Discovery to First-in-man Setup in Cancer Immunotherapy

openalex（2023）

Cited0Views0Bibtex

EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective C-Met Inhibitors

Friedhelm Bladt,Bettina Faden,Manja Friese-Hamim,Christine Knuehl,Claudia Wilm,Claus Fittschen,Ulrich Gr Adler,Michael Meyring,Dieter Dorsch,Frank Jaehrling,Ulrich Pehl,Frank Stieber,Oliver Schadt,Andree Blaukat

crossref（2023）

Cited110Views0WOSBibtex

110

Supplementary Figure 21 from Arginase 1/2 Inhibitor OATD-02: from Discovery to First-in-man Setup in Cancer Immunotherapy

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 4 from EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective C-Met Inhibitors

Friedhelm Bladt,Bettina Faden, Manja Friese‐Hamim,Christine Knuehl,Claudia Wilm,Claus Fittschen,Ulrich Grädler,Michael Meyring, Dieter Dorsch,Frank Jaehrling,Ulrich Pehl,Frank Stieber,Oliver Schadt,Andree Blaukat

openalex（2023）

Cited0Views0Bibtex

Supplementary Materials and Methods from Arginase 1/2 Inhibitor OATD-02: from Discovery to First-in-man Setup in Cancer Immunotherapy

openalex

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn